San Diego, California, July 19, 2005 - Solulink, Inc., an innovator of novel biomolecular linking and conjugation chemistry for the pharmaceutical and diagnostic industries, today announced that the U.S. Patent & Trademark Office has issued to Solulink U.S. Patent number 6,911,535, Biomolecule/Polymer Conjugates. The patent further strengthens Solulink’s position as a leader in the application of conjugation chemistry to facilitate common biomedical research and product applications.
